DAUNORUBICIN

Cerubudine

Indication:

It is used in the treatment of Acute Myelogenous Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL). It may be used in combination with other medicines. It may also be used for other conditions as determined by your doctor.

Brand name:Cerubudine

Active Ingeridents:Daunorubicin

Company Name:Erfa

Package: Vial

Strength :20 mg

Mechanism of action:

Cerubidine (Daunorubicin) has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Cerubidine (Daunorubicin) forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes.

Dosage and Administration:

Cerubidine (Daunorubicin) is given by intravenous injection (IV). The syringe needle is placed directly into the tubing of a freely flowing IV solution into a vein or central line and the drug is given over several minutes.

Cerubidine (Daunorubicin) is a vesicant. A vesicant is a chemical that causes extensive tissue damage and blistering if it escapes from the vein. The nurse or doctor who gives this drug must be carefully trained. If you notice redness or swelling at the IV site while you are receiving Cerubidine (Daunorubicin) , alert your health care professional immediately.

The amount of Cerubidine (Daunorubicin) you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer you have. Your doctor will determine your dose and schedule.

Store:

Cerubidine (Daunorubicin) is usually handled and stored by a health care provider. If you are using Cerubidine (Daunorubicin) at home, store Cerubidine (Daunorubicin) as directed by your pharmacist or health care provider. Keep Cerubidine (Daunorubicin) out of the reach of children and away from pets.

Side effects:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Do not receive any kind of immunization or vaccination without your doctor's approval while taking Cerubidine (Daunorubicin) .

You may be more sensitive to sunlight, take extra care to avoid sun exposure.

People with congestive heart failure, those who have already had high doses of this drug or a similar drug, and those with permanent problems with blood counts (bone marrow suppression) cannot receive this drug.

Warning

Cerubidine is a prescription drug and should be used under proper medical guidance and advice. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Daunomycin

Indication:

It is used in the treatment of Acute Myelogenous Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL). It may be used in combination with other medicines. It may also be used for other conditions as determined by your doctor.

Brand name: Daunomycin

Active Ingeridents: Daunorubicin

Company Name: Pfizer

Package: Vial

Strength :20 mg

Mechanism of action:

Daunomycin (Daunorubicin) has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Daunomycin (Daunorubicin) forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes.

Dosage and Administration:

Daunomycin (Daunorubicin) is given by intravenous injection (IV). The syringe needle is placed directly into the tubing of a freely flowing IV solution into a vein or central line and the drug is given over several minutes.

Daunomycin (Daunorubicin) is a vesicant. A vesicant is a chemical that causes extensive tissue damage and blistering if it escapes from the vein. The nurse or doctor who gives this drug must be carefully trained. If you notice redness or swelling at the IV site while you are receiving Daunomycin (Daunorubicin) , alert your health care professional immediately.

The amount of Daunomycin (Daunorubicin) you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer you have. Your doctor will determine your dose and schedule.

Store:

Daunomycin (Daunorubicin) is usually handled and stored by a health care provider. If you are using Daunomycin (Daunorubicin) at home, store Daunomycin (Daunorubicin) as directed by your pharmacist or health care provider. Keep Daunomycin (Daunorubicin) out of the reach of children and away from pets.

Side effects:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Do not receive any kind of immunization or vaccination without your doctor's approval while taking Daunomycin (Daunorubicin) .

You may be more sensitive to sunlight, take extra care to avoid sun exposure.

People with congestive heart failure, those who have already had high doses of this drug or a similar drug, and those with permanent problems with blood counts (bone marrow suppression) cannot receive this drug.

WARNING:

Daunomycin is a prescription drug and should be used under proper medical guidance and advice. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Daunorubitec

Indication:

It is used in the treatment of Acute Myelogenous Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL). It may be used in combination with other medicines. It may also be used for other conditions as determined by your doctor.

Brand name:Daunorubitec

Active Ingeridents: Daunorubicin

Company Name:United Biotech

Package:Vial

Strength :20 mg

Mechanism of action:

Daunorubitec (Daunorubicin) has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Daunorubitec (Daunorubicin) forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes.

Dosage and Administration:

Daunorubitec (Daunorubicin) is given by intravenous injection (IV). The syringe needle is placed directly into the tubing of a freely flowing IV solution into a vein or central line and the drug is given over several minutes.

Daunorubitec (Daunorubicin) is a vesicant. A vesicant is a chemical that causes extensive tissue damage and blistering if it escapes from the vein. The nurse or doctor who gives this drug must be carefully trained. If you notice redness or swelling at the IV site while you are receiving Daunorubitec (Daunorubicin) , alert your health care professional immediately.

The amount of Daunorubitec (Daunorubicin) you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer you have. Your doctor will determine your dose and schedule.

Store:

Daunorubitec (Daunorubicin) is usually handled and stored by a health care provider. If you are using Daunorubitec (Daunorubicin) at home, store Daunorubitec (Daunorubicin) as directed by your pharmacist or health care provider. Keep Daunorubitec (Daunorubicin) out of the reach of children and away from pets.

Side effects:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Do not receive any kind of immunization or vaccination without your doctor's approval while taking Daunorubitec (Daunorubicin) .

You may be more sensitive to sunlight, take extra care to avoid sun exposure.

People with congestive heart failure, those who have already had high doses of this drug or a similar drug, and those with permanent problems with blood counts (bone marrow suppression) cannot receive this drug.

WARNING:

Daunorubitec is a prescription drug and should be used under proper medical guidance and advice. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Daunotec

Indication:

It is used in the treatment of Acute Myelogenous Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL). It may be used in combination with other medicines. It may also be used for other conditions as determined by your doctor.

Brand name:Daunotec

Active Ingeridents:Daunorubicin

Company Name: Cipla

Package: Vial

Strength :20 mg

Mechanism of action:

Daunotec (Daunorubicin) has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Daunotec (Daunorubicin) forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes.

Dosage and Administration:

Daunotec (Daunorubicin) is given by intravenous injection (IV). The syringe needle is placed directly into the tubing of a freely flowing IV solution into a vein or central line and the drug is given over several minutes.

Daunotec (Daunorubicin) is a vesicant. A vesicant is a chemical that causes extensive tissue damage and blistering if it escapes from the vein. The nurse or doctor who gives this drug must be carefully trained. If you notice redness or swelling at the IV site while you are receiving Daunotec (Daunorubicin) , alert your health care professional immediately.

The amount of Daunotec (Daunorubicin) you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer you have. Your doctor will determine your dose and schedule.

Side effects:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Store:

Daunotec (Daunorubicin) is usually handled and stored by a health care provider. If you are using Daunotec (Daunorubicin) at home, store Daunotec (Daunorubicin) as directed by your pharmacist or health care provider. Keep Daunotec (Daunorubicin) out of the reach of children and away from pets.

Do not receive any kind of immunization or vaccination without your doctor's approval while taking Daunotec (Daunorubicin) .

You may be more sensitive to sunlight, take extra care to avoid sun exposure.

People with congestive heart failure, those who have already had high doses of this drug or a similar drug, and those with permanent problems with blood counts (bone marrow suppression) cannot receive this drug.

WARNING:

Daunotec is a prescription drug and should be used under proper medical guidance and advice. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.